(1)
Kader, S.; J.Al-Shamma, K.; A. Majeed, I.; T. Al-Ani, A. Comparative Study Between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences 2017, 18 (2), 32-38. https://doi.org/10.31351/vol18iss2pp32-38.